Vital Signs - Plotting the Telehealth Market Spectrum


USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This issue of Vital Signs, released on April 11, 2011, provides a strategic insight on the telehealth market. Additionally, a company spotlight is provided for Cardiocom, a company that prominently works on diabetes and cardiac monitoring solutions. Reimbursement and regulatory news from the FDA is also provided for week of March 21, 2011.

Table of Contents

Vital Signs - Plotting the Telehealth Market SpectrumVital Signs: 11 Mar 2011This week's issue

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.